Research on the effects of supplementing broiler diets with Lion’s mane (Hericium erinaceus) and Reishi Mushroom (Ganoderma lucidum) was conducted in the field from March 22, 2022, to April 18, 2022, by the Department of Animal Production in the College of Agricultural Engineering Sciences at the University of Baghdad in Abu Ghraib. There were a total of 210 one-day-old Ross 308 broiler chicks employed in this study (10 birds per replicate), and they were fed a starter diet for the first 10 days, a growth diet for the next 11-24 days, and a final diet for the last 25-42 days. The birds were randomly assigned to one of seven treatments, with three replicates per treatment and ten birds in each replicate. The experimental procedures included:Treatment 1 (T1) is a diet with no extra ingredients. The second diet (T2) includes 1 g/kg of lion’s mane (Hericium erinaceus) fodder, the third diet (T3) includes 1.5 g/kg of lion’s mane (Hericium erinaceus), and the fourth diet (T4) includes 2 g/kg of lion’s mane (Hericium erinaceus), the fifth diet (T5) includes 1 g/kg of reishi mushroom (Ganoderma Treatments T4 (2 g/kg of Lion’s mane (Hericium erinaceus) and T6 (1.5 gm of Reishi Mushroom (Ganoderma lucidum)) were superior on the control treatment T1 in the sixth week, while in the fifth week, treatment T6 (1.5 g/kg of Reishi Mushroom) showed a significant increase in weekly average body weight over the control treatment T1. The ratio of weight gain to treatment time was found to be significantly higher for treatments T4 and T6 compared to the control treatment T1 (P<0.01). At 6 weeks of age, the feed consumption ratio increased significantly for treatments T5, T6, and T7 compared to the control treatment T1, and a high significant improvement (P<0.01) in the feed conversion ratio was observed, most notably for the birds in treatment T4, to which Lion’s mane (Hericium erinaceus) was added to their diets at a rate of 2 g / kg. There was a significant (P≤0.05) increase in the relative weight of the liver for birds of treatment T2 (1g/kg Lion’s mane (Hericium erinaceus) and T6 (1.5g/kg Reishi Mushroom (Ganoderma lucidum)) compared to the control treatment T1. The results of this investigation suggest that varying concentrations of Lion’s mane (Hericium erinaceus) and Reishi Mushroom (Ganoderma lucidum) may help boost grill performance.
Abstract: non-alcoholic fatty liver disease (NAFLD) is one of the widespread chronic liver diseases; it is ranging from simple fat buildup in the liver (steatosis) to non-alcoholic steatohepatitis (NASH) presence of inflammation and hepatocyte injury. &nb
... Show MoreDyes are extensively water-soluble and toxic chemicals. The disposing of wastewater rich with such chemicals has severely impacted surface water quality (rivers and lakes). In the current study, an anionic dye, methyl orange, were extracted from wastewater fluids using bulk liquid membranes supplemented with an anionic carrier (Aliquat 336 (QCI)). Parameters including solvent type (carbon tetrachloride and chloroform), membrane stirring speed (100-250 rpm), mixing speed of both phases (50-100 rpm), The feed pH (2-12) and implemented temperature (35-60 °C) were thoroughly analyzed to determine the effect of such variables on extraction effectiveness. Furthermore, the effect of methyl orange (10-50 ppm) in the feed stage and NaOH (0
... Show MoreThe temperature control process of electric heating furnace (EHF) systems is a quite difficult and changeable task owing to non-linearity, time delay, time-varying parameters, and the harsh environment of the furnace. In this paper, a robust temperature control scheme for an EHF system is developed using an adaptive active disturbance rejection control (AADRC) technique with a continuous sliding-mode based component. First, a comprehensive dynamic model is established by using convection laws, in which the EHF systems can be characterized as an uncertain second order system. Second, an adaptive extended state observer (AESO) is utilized to estimate the states of the EHF system and total disturbances, in which the observer gains are updated
... Show MoreThe study aimed to evaluate the level of MMP‑2 in acute myeloid leukemia (AML) patients in comparison with that in remission status, and healthy subjects, and to find its correlation with hematologic parameters. This study included sixty newly diagnosed AML patients. Remission status was assessed after induction chemotherapy. The overall survival (OS) was determined after 6 months. The plasma MMP‑2 level was measured at diagnosis by enzyme immunoassay. Twenty‑eight healthy individuals were recruited as a control group. Plasma MMP‑2 was higher in AML patients than in healthy individuals (P = 0.005). The level of MMP‑2 was much higher in the M5 subtype than in the other subtypes (P = 0.0001). There was no statistically significant d
... Show More